Ghent , Belgium
December 13, 2007
Devgen today announced that Wim Goemaere will join the
Company as new CFO, effective January 7, 2008. Mr. Goemaere
previously held the position of CFO at VIB (the Flanders
Institute for Biotechnology) in Ghent. Mr. Goemaere brings 20
years of industry experience in corporate finance and financial
management. Wim Goemaere replaces Hilde Windels, who has taken
charge of Devgen's pharma business unit.
Wim held the position of CFO at VIB which is a research
institution employing over 1000 researchers. At VIB, his
responsibilities included finance and control, tax management,
corporate information technology and corporate legal issues. He
was instrumental in building and shaping VIB together with the
other members of the management team. Wim originally joined VIB
in 1995.
Wim started his career with BP Chemicals in Antwerp in 1987 as
analyst and he held various other positions at BP until he was
appointed controller at BP Belgium NV in 1993 until 1995 when he
joined VIB.
Wim holds a degree in applied economics.
Devgen is a top 10 public agro biotech company with
agricultural business units focused on developing and
commercializing:
• a novel generation of biotech products to protect a wide
spectrum of crops from damage incurred from pests;
• biotech traits and germplasm to meet the growing needs for
high yielding, high quality hybrid rice and selected small
grains in India and S.E. Asia;
• safer and more environmentally friendly agro-chemical products
to protect crops from damage inflicted by plant parasitic
nematodes.
Devgen and Monsanto have an agreement in place for Devgen's
research and is coupled with an agreement which broadens the
relationship so that both companies can explore technology
applications in their crop areas of interest.
Devgen's biopharmaceutical division develops a new class of
preclinical drug candidates, based on novel therapeutic
concepts, for treatment of a range of inflammatory and metabolic
disease (diabetes, obesity) and arrhythmia.
Devgen has entered into partnerships with industry leaders in
biotechnology and agro chemistry. Incorporated in 1997, Devgen
has offices in Ghent (Belgium), Singapore and Hyderabad (India),
with a total work force of about 160 people, including Devgen
seeds and crop technologies, India. Devgen is listed on Eurolist
by Euronext Brussels (ticker: DEVG) since June 2005. |
|
